May 29, 2019 / NTS GMT
RenéC. Goehrum - BioSyent Inc. - Chairman, CEO & President
Hello, and welcome to the BioSyent Q1 2019 results presentation. My name is René Goehrum, and I'm the President and CEO of the company.
I'll draw your attention to our disclaimer on forward-looking statements and start the presentation with a look at our sales, EBITDA and net income after tax for the first quarter.
So to draw your attention to the right side of the screen, you can see our sales overall were up 1% versus year ago, our EBITDA down 19% and our net income after tax down 14% when compared to year ago. So a couple of comments generally on profitability and on revenue. So this quarter represented our 35th consecutive profitable quarter. So for those keeping score, that's almost 9 years.
Our Pharma business in Canada is strong, showed 13% growth measured in dollars in the first quarter versus year ago. Our International Pharma business has got an unusual number there. It's minus 100%. So in the quarter, we didn't ship any orders to customers for our International Pharma business. And I've got
Q1 2019 Biosyent Inc Earnings Call Transcript
May 29, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers